Clinical Trials Logo

Lung Ultrasound clinical trials

View clinical trials related to Lung Ultrasound.

Filter by:

NCT ID: NCT04368338 Completed - Covid-19 Clinical Trials

Lung Ultrasound to Diagnose COVID-19

COVILUS
Start date: April 28, 2020
Phase:
Study type: Observational

Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.

NCT ID: NCT04338568 Recruiting - COVID-19 Pneumonia Clinical Trials

Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study

SCOUT
Start date: April 16, 2020
Phase: N/A
Study type: Interventional

COVID-19 is a rapidly spreading and very contagious disease caused by a novel coronavirus that can lead to respiratory insufficiency. In many patients, the chest radiograph at first presentation be normal, and early low-dose CT-scan is advocated to diagnose viral pneumonia. Lung ultrasound (LUS) has similar diagnostic properties as CT for diagnosing pneumonia. However, it has the advantage that it can be performed at point-of-care, minimizing the need to transfer the patient, reducing the number of health care personnel and equipment that come in contact with the patient and thus potentially decrease the risk of spreading the infection. This study has the objective to examine the accuracy of lung ultrasound in patients with proven COVID-19 pneumonia.

NCT ID: NCT04057625 Not yet recruiting - Clinical trials for Ventilator Associated Pneumonia

Transthoracic Ultrasound in the Diagnosis and Follow-up of Ventilator Associated Pneumonia

Start date: September 2019
Phase: N/A
Study type: Interventional

To evaluate the sensitivity, specificity and diagnostic accuracy of bedside transthoracic ultrasound examination in the diagnosis and follow up of ventilator associated pneumonia.

NCT ID: NCT03912311 Not yet recruiting - Clinical trials for One-lung Ventilation

Auscultation, Lus, Fob In Olv (ALFIO)

ALFIO
Start date: April 2, 2019
Phase:
Study type: Observational [Patient Registry]

The study will be to demonstrate that, in patients undergoing elective thoracic surgery, lung ultrasound (LUS) in OR is more sensitive, specific and accurate method than thoracic auscultation, for the evaluation of OLV. The aim of the study is to demonstrate how lung ultrasound can be considered an attractive alternative to the routine use of fiberbronchoscope as a first line diagnostic tool to verify the correct position of left double lumen tube.

NCT ID: NCT03619525 Recruiting - Lung Ultrasound Clinical Trials

Ultrasonographic Assessment of the Effect of CPB Acute Lung Injury

CBP
Start date: October 20, 2018
Phase: N/A
Study type: Interventional

The study is designed to use the lung ultrasound to assess the effect of intermittent lung recruitment during cardiopulmonary bypass in cardiac surgeries on extra vascular lung water.

NCT ID: NCT03546699 Active, not recruiting - Respiratory Failure Clinical Trials

Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS

Start date: October 24, 2018
Phase:
Study type: Observational

The Acute Respiratory Distress Syndrome (ARDS) impacts one of every four patients requiring mechanical ventilation for respiratory support and carries a mortality rate of 40%. To diagnose ARDS, doctors currently use the Berlin definition, that requires chest radiographs and analysis of oxygenation in the blood (arterial blood gas). These tests are not available in areas of the world with constrained resources and may be unnecessarily invasive. A modification of the Berlin definition, using ultrasound and pulse oximetry (a small device that measures oxygen level non-invasively by clipping to the body, typically a finger), has been recently developed and tested in Kigali, Rwanda. This study will try to confirm the validity of the Kigali modification initially in Boston and Toronto and subsequently in other hospitals worldwide. If confirmed, this new definition could allow for faster recognition and potentially improved treatment of patients with ARDS and facilitate studies worldwide. The purposes of this study are: 1. To describe clinical characteristics and outcomes of patients diagnosed with ARDS according to the Berlin and Kigali definitions; 2. To determine how well chest radiograph and ultrasound of the chest are able to define ARDS, in comparison to chest computer tomography (CT).

NCT ID: NCT02556853 Terminated - Lung Ultrasound Clinical Trials

Ultrasound for Double Lumen Endotracheal Tube

Start date: September 2015
Phase: N/A
Study type: Interventional

The patients will be allocated to 2 groups: the ultrasound group and the clinical group. The correct position of the double lumen tube will be determined by ultrasound (Sonoscape S6®) for the patients of the one group (group U) and by clinical examination for the patients of the other group (group C). The correct placement will be verified by bronchoscopy (Pentax®). The two methods will be compared in terms of sensitivity and specificity. The main purpose of the study is to determine if the ultrasound can be used for determination of the correct placement of the left sided double lumen endotracheal tube